AbbVie Completes Acquisition of Cerevel Therapeutics
Go back to AbbVie Completes Acquisition of Cerevel Therapeutics| AbbVie (NYSE: ABBV) | Delayed: 265.49 +6.57 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $258.92 | 52 Week High | $68.12 | |||
| Open | $261.51 | 52 Week Low | $50.71 | |||
| Day High | $266.41 | P/E | 57.59 | |||
| Day Low | $259.55 | EPS | $4.61 | |||
| Volume | 2,407,423 | |||||
| CERES (NASDAQ: CERE) | Delayed: 44.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.96 | 52 Week High | $4.80 | |||
| Open | $44.96 | 52 Week Low | $0.16 | |||
| Day High | $44.96 | P/E | N/A | |||
| Day Low | $44.96 | EPS | $-1.36 | |||
| Volume | 2,646 | |||||
